Company profile for Biopharmaceutical Research Company

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

BRC’s develops federally compliant active pharmaceutical ingredients (API) for plant-based therapeutics, with uncompromising quality, for patients and researchers everywhere. BRC was founded to address the needs of America's scientific community for diverse types of research quality and CFR-compliant cannabis and to provide USDA-compliant hemp testing. We take our responsibility to provide the scientific community with super...
BRC’s develops federally compliant active pharmaceutical ingredients (API) for plant-based therapeutics, with uncompromising quality, for patients and researchers everywhere. BRC was founded to address the needs of America's scientific community for diverse types of research quality and CFR-compliant cannabis and to provide USDA-compliant hemp testing. We take our responsibility to provide the scientific community with superior quality cannabis seriously. BRC serves the public interest because it is a United States Department of Veterans Affairs certified Service-Disabled Veteran-Owned Business ("SDVOB"). We are also creating jobs.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
Castroville Blvd, Castroville, California 95012
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.prnewswire.com/news-releases/stephen-wright-md-joins-brc-therapeutics-as-development-advisor-302454473.html

PR NEWSWIRE
14 May 2025

https://www.prnewswire.com/news-releases/biopharmaceutical-research-company-brc-announces-development-and-regulatory-milestone-following-successful-type-c-cmc-meeting-with-fda-advancing-clinical-development-of-multiple-therapeutic-candidates-302362617.html

PR NEWSWIRE
29 Jan 2025

https://www.prnewswire.com/news-releases/biopharmaceutical-research-company-announces-first-dose-of-brc-002-a-first-in-class-cannabinoid-therapeutic-for-complex-regional-pain-syndrome-crps-in-investigator-initiated-study-302266003.html

PR NEWSWIRE
03 Oct 2024

https://www.prnewswire.com/news-releases/city-of-hope-and-biopharmaceutical-research-company-announce-first-patient-has-received-brc-001-a-first-in-class-cannabinoid-therapeutic-in-a-clinical-trial-investigating-supportive-care-in-breast-cancer-302246818.html

PR NEWSWIRE
12 Sep 2024

https://www.prnewswire.com/news-releases/dea-licensed-pharmaceutical-cannabis-company-biopharmaceutical-research-company-brc-announces-20m-series-a-funding-round-301640321.html

PRNEWSWIRE
04 Oct 2022

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty